Viewing StudyNCT00125021



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00125021
Status: COMPLETED
Last Update Posted: 2009-11-01
First Post: 2005-07-27

Brief Title: Tarceva and Capecitabine for Pancreatic Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Neoplasm Metastasis
Pancreatic Cancer
Keywords:
Name View
Metastatic Pancreatic Cancer View
Second Line Therapy View
Gemcitabine Refractory View
Pancreatic Cancer View
Capecitabine View
Tarceva View
OSI-774 View